Andreas Hochhaus

Publications

• The Acetyltransferase GCN5 Maintains ATRA-resistance in Non-APL AML
  Leukemia. Nov, 2019  |   Pubmed ID: 31576004
• Fast and Quantitative Evaluation of Human Leukocyte Interaction with Aspergillus Fumigatus Conidia by Flow Cytometry
  Cytometry. Part A : the Journal of the International Society for Analytical Cytology. Mar, 2019  |   Pubmed ID: 30450827
• Human MAIT cells Are Rapidly Activated by Aspergillus Spp. in an APC-dependent Manner
  European Journal of Immunology. 10, 2018  |   Pubmed ID: 30059139
• Questions Arising on Phlebotomy in Polycythemia Vera: Prophylactic Measures to Reduce Thromboembolic Events Require Patient-focused Decisions
  Leukemia. 09, 2018  |   Pubmed ID: 30042412
• Targeting HSP90 Dimerization Via the C Terminus is Effective in Imatinib-resistant CML and Lacks the Heat Shock Response
  Blood. 07, 2018  |   Pubmed ID: 29724897
• Ponatinib Efficacy and Safety in Philadelphia Chromosome-positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial
  Blood. 07, 2018  |   Pubmed ID: 29567798
• Managing Myeloproliferative Neoplasms Evidence Based on the ELN Treatment Recommendations 2018
  Leukemia. 05, 2018  |   Pubmed ID: 29515237
• Overall Survival with Ponatinib Versus Allogeneic Stem Cell Transplantation in Philadelphia Chromosome-positive Leukemias with the T315I Mutation
  Cancer. Aug, 2017  |   Pubmed ID: 28387926
• Nilotinib First-line Therapy in Patients with Philadelphia Chromosome-negative/BCR-ABL-positive Chronic Myeloid Leukemia in Chronic Phase: ENEST1st Sub-analysis
  Journal of Cancer Research and Clinical Oncology. Jul, 2017  |   Pubmed ID: 28224300
• Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2017  |   Pubmed ID: 27856601
• Chronic Persistent Parvovirus B19 Bone Marrow Infection Resulting in Transfusion-dependent Pure Red Cell Aplasia in Multiple Myeloma After Allogeneic Haematopoietic Stem Cell Transplantation and Severe Graft Versus Host Disease
  Hematology (Amsterdam, Netherlands). Mar, 2017  |   Pubmed ID: 27311084
• Impact of Dose Intensity of Ponatinib on Selected Adverse Events: Multivariate Analyses from a Pooled Population of Clinical Trial Patients
  Leukemia Research. 09, 2016  |   Pubmed ID: 27505637
• Lymphocytosis After Treatment with Dasatinib in Chronic Myeloid Leukemia: Effects on Response and Toxicity
  Cancer. May, 2016  |   Pubmed ID: 26998677
• Nilotinib in Patients with Systemic Mastocytosis: Analysis of the Phase 2, Open-label, Single-arm Nilotinib Registration Study
  Journal of Cancer Research and Clinical Oncology. Nov, 2015  |   Pubmed ID: 26002753
• [Chronic Myelogenous Leukemia]
  Der Internist. Apr, 2015  |   Pubmed ID: 25860113
• Causes of Resistance and Treatment Choices of Second- and Third-line Treatment in Chronic Myelogenous Leukemia Patients
  Annals of Hematology. Apr, 2015  |   Pubmed ID: 25814079
• Adjuvant Therapy Sparing in Rectal Cancer Achieving Complete Response After Chemoradiation
  World Journal of Gastroenterology. Nov, 2014  |   Pubmed ID: 25400468
• Effect of the Tyrosine Kinase Inhibitor Nilotinib in Patients with Hypereosinophilic Syndrome/chronic Eosinophilic Leukemia: Analysis of the Phase 2, Open-label, Single-arm A2101 Study
  Journal of Cancer Research and Clinical Oncology. Dec, 2013  |   Pubmed ID: 24057647
• The Development of Dasatinib As a Treatment for Chronic Myeloid Leukemia (CML): from Initial Studies to Application in Newly Diagnosed Patients
  Journal of Cancer Research and Clinical Oncology. Dec, 2013  |   Pubmed ID: 23942795
• Differential Effects of Dosing Regimen on the Safety and Efficacy of Dasatinib: Retrospective Exposure-response Analysis of a Phase III Study
  Clinical Pharmacology : Advances and Applications. 2013  |   Pubmed ID: 23788844
• Impact of NOD2 Polymorphisms on Infectious Complications Following Chemotherapy in Patients with Acute Myeloid Leukaemia
  Annals of Hematology. Aug, 2013  |   Pubmed ID: 23558906
• Nilotinib is Associated with a Reduced Incidence of BCR-ABL Mutations Vs Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
  Blood. May, 2013  |   Pubmed ID: 23502220
• [Tailored Management of Chronic Myeloid Leukemia]
  Der Internist. Feb, 2013  |   Pubmed ID: 23371258
• Isolated Central Nervous System Relapse of Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
  BMC Blood Disorders. 2012  |   Pubmed ID: 22871019
• Rac2-MRC-cIII-generated ROS Cause Genomic Instability in Chronic Myeloid Leukemia Stem Cells and Primitive Progenitors
  Blood. May, 2012  |   Pubmed ID: 22411871
• Ponatinib May Overcome Resistance of FLT3-ITD Harbouring Additional Point Mutations, Notably the Previously Refractory F691I Mutation
  British Journal of Haematology. May, 2012  |   Pubmed ID: 22409268
• Imatinib and Beyond--targeting Activated Tyrosine Kinases in Myeloproliferative Disorders
  Onkologie. 2012  |   Pubmed ID: 22286586
• Educational Session: Managing Chronic Myeloid Leukemia As a Chronic Disease
  Hematology. American Society of Hematology. Education Program. 2011  |   Pubmed ID: 22160024
• [Chronic Myeloid Leukemia]
  Deutsche Medizinische Wochenschrift (1946). Oct, 2011  |   Pubmed ID: 21960328
• Impact of BCR-ABL Mutations on Patients with Chronic Myeloid Leukemia
  Cell Cycle (Georgetown, Tex.). Jan, 2011  |   Pubmed ID: 21220945
• Dasatinib-associated Major Molecular Responses in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Imatinib Failure: Response Dynamics and Predictive Value
  Leukemia. Sep, 2009  |   Pubmed ID: 19641527